Intellisphere Takes Docs to the Web
Korean Pharma Expands at Carnegie
Corrections or additions?
This article by Barbara Fox was prepared for the December 4, 2002 edition of U.S. 1 Newspaper. All rights reserved.
Healthcare on the Move: MultiMedia Healthcare/Freedom
Robert Preston, the new CEO of MultiMedia Healthcare/Freedom
at Princeton Meadows Office Center, has introduced a free magazine
now being distributed at 4,100 CVS pharmacies nationwide. With the
title “Family Health Matters: A Woman’s Guide to Family Medicine,”
this quarterly magazine aims to reach the lucrative women’s market.
Women make 75 percent of the healthcare decisions in the United States,
according to one recent study, and women spend nearly two out of every
three healthcare dollars. Preston says that the nearly 1 million copies
of this new magazine — the first consumer publication to focus
on gender-specific health — could reach up to 35 million customers
each month. Each issue features a specific health topic that affects
women and their families, from bone and heart health to aging and
stress management.
“This is an opportunity to diversify our revenue — we are
going after the direct-to-patient consumer bucket,” says Preston.
“Our focus is to become insulated from the ups and downs of journal
advertising and become more dependent on medical education dollars.
Most medical publishing companies are doing both. Everybody is trying
to get a piece of this money because it seems to be endless. Clients
may not have journal advertising money but they always have medical
education money.”
“We knew the market was out there, and we are securing the distribution
through CVS. This aligns with the CVS business model that the female
is making more of the health related decisions — their stores
are set up for women,” says Preston.
“How we try to distinguish ourselves,” says Preston, “is
with credentialized marketing. Every medical education piece we put
out, every journal article, is associated with a leading association
or institution.” American Family Health Matters, for instance,
“has content that readers can trust because it’s backed by the
authority of Columbia University, a world-class institution.”
The editor is Marianne J. Legato MD, founder of the Partnership for
Gender-Specific Medicine and a professor at Columbia.
“The changing medical landscape is making women’s lives more complicated
than ever,” Legato says. “Our goal is to arm women with the
information they need to make educated decisions — for themselves
and for their families.”
Preston majored in business at Montclair State, Class of 1977, and
started out selling ad space for the Patterson News. He has been in
healthcare publishing for more than two decades. Before taking this
job he had been group publisher in Montvale for Medical Economics
Thomson Healthcare.
Marjorie Schulz is editorial director for the company, a division
of Freedom Magazines, that also publishes the Journal of Gender-Specific
Medicine, a peer-reviewed journal that is the official publication
of the Partnership for Gender-Specific Medicine at Columbia. Its other
publications are Clinical Geriatrics, the Annals of Long-Term Care,
and Home Health Care Consultant. In addition it sponsors meetings
and other medical education programs for health care professionals.
A billion dollar, privately held firm, Freedom’s flagship publication
is the Orange County Register, and it has other daily and weekly newspapers
plus eight television stations. Last year it exercised an option to
buy all of Multimedia Healthcare (U.S. 1, March 20). Since then Multimedia
Healthcare has grown from 23 to 29 employees at this location.
Warren A. Dardine, president of the Pennsylvania-based Programs In
Medicine, was in charge of launching this magazine project. The launch
issue was just 20 pages, says Dardine, and he expects it to grow to
32 pages. A 1976 graduate of Weidner University, he did graduate work
at Penn medical school and then worked in marketing for Wyeth and
an ad agency. “We wanted to secure a minimum number of advertisers
and introduce it as a highly credentialed publication. There was high
interest but we were moving rather rapidly. I can’t tell you
how many contacts we made and those contacts are now coming through,”
says Dardine.
Multimedia Healthcare/Freedom LLC, 666 PlainsboroRoad, Suite 440, Plainsboro 08536. Robert Preston, CEO. 609-275-3800;fax, 609-716-8138. Home page: www.mmhc.comTop Of PageIntellisphere Takes Docs to the WebIntellisphere, the medical education company that focuseson explaining the Internet to doctors, and that once was a part ofMultimedia Healthcare, thinks that doctors are moving to the “pointof sale” mentality. Instead of browsing a medical journal forarticles that catch their eye, they are doing more targeted researchon the Internet.”The readership among highly clinical journals is starting toflatten and trail off,” says Herb Marek, COO of Intellisphere.”Doctors are going to Medline or one of the other good medicalsites to get information on a particular disease in a particular demographicand going right to the article.”Intellisphere publishes MD Net Guide, Oncology Net Guide, and FamilyMedicine Net Guide, and it has just spun off eight specialty publications— for cardiology, endocrinology, respiratory, gastroenterology,psychiatry, neurology, and rheumatology.”We try to enhance the physician’s knowledge of how to use thehardware and software to get the best out of the Internet and providethe direct links to the best medical education and clinical informationsites,” says Marek. A graduate of Kean College, he has master’sdegrees from Rutgers and Fairleigh Dickinson. He stayed with Intellispherewhen the company split, with half going to Multimedia Healthcare/FreedomLLC (see article above) and Michael Hennessey owning the Intellispherehalf (U.S. 1, March 20).”We tested the waters and will have four issues of Family NetGuide next year,” says Marek. “We scour the net for new medicalcontent, our editorial board evaluates it, and it ends up in our journal.”Clinical and practice management information comprise 90 percent ofthe content, and leisure links (those ads for sailboats and luxurycars) just 10 percent. This information is also available online (foreasy clicking through) and on E-mail newsletters but print ads arethe cash cows of the publishing business, he admits. “Our onlineversions provide added value to our advertisers.”The proof of success is in the page numbers. The September issue forprimary care physicians was 54 pages, and the specialty magazinesare 32-36 pages. To put this in perspective, the medical informationindustry is down 13 percent in pages, in the year to date, yet eventaking into account the fact that Intellisphere operates from a relativelysmall baseline, its page count is up 50 percent.Intellisphere, 666 Plainsboro Road, Suite 300,Plainsboro 08536. Michael Hennessey, CEO. 609-716-7777; fax, 609-716-4747.Home page: www.mdnetguide.comTop Of PageNew in Town: MediMaxMediMax Communications Inc. plans medical initiativesfor pharmaceutical companies. Based in Durham (its first major clientis a pharmaceutical company in the Research Triangle), it has nineemployees. Partners Staci Cunliffe and Joanne Rosenberg founded thecompany in 1999 and opened the Carnegie Center office in September.”We moved to Princeton because we are trying to expand our northeastbusiness, and this is the pharmaceutical hub,” says Rosenberg.Cunliffe went to the University of Nebraska, Class of 1990, and didsocial work in England for two years, then worked for a not-for-profitdoing grant writing, business development, and educational programs.Ten years ago she moved to a medical education field for major clinicalresearch organizations.A native of Jackson, New Jersey, Rosenberg went to State Universityof New York at Downstate Medical Center in Brooklyn, where she learnedto perform to be a sonographer (performing high risk ultrasounds).”Part of my job was planning medical meetings, and I decided that’swhat I love to do,” she says. “We are strategic partners withpharmaceutical companies to plan strategic medical initiatives indifferent therapeutic areas. When they have a drug coming to market,we help them plan initiatives around the launch of that drug. To educatephysicians, we do anything from journal supplements to arranginga teleconference series, creating advisory boards, and holding speakertraining meetings.””Because we come from medical and human services backgrounds,we have more of a scientific spin to our peer development programsand our strategic thinking, versus the advertising approach,”says Cunliffe. “Every person on the account team must do a tutorialon the therapeutic area and the products related to the treatmentof the disease, so that they have a knowledge base. We are the eyesand ears for the client.”MediMax Communications Inc., 212 Carnegie Center,Carnegie Executive Center, Suite 206A, Princeton 08540. 609-919-6330;fax, 609-520-1806. Stacy Cunliffe and Joanne Rosenberg, partners.E-mail: sales@medimaxcom.net.Top Of PageExpansions: CytocomThis full service, international healthcare communicationcompany moved from Forrestal Village to Clarksville Road, where ithas 18 employees. It had been purchased by Rose Worldwide, a holdingcompany that is in turn owned by Habas, the fifth largest advertisingand communications company in the world.Among the Rose Worldwide companies are an advertising firm, RobertA. Becker, and a medical education company in Trevose, Pennsylvania.For major pharmaceutical corporations, Cytocom offers business strategy,communications for current and new products, medical education, medicalwriting, and publications. Clients include Amgen, Sanofi-Synthelabo,Pharmacia, Centocor, and Wyeth.After 11 years experience in the pharmaceutical industry, Gordon Beckstarted his company in his home, and he named it after the word forcell plus com for communications. A bachelor and a 1985 graduate ofthe University of Kansas, he lives in Princeton in Bainbridge Estates.His father worked for the Army as director of a hospital, and hismother was a pharmacist.Beck worked at Hoffman LaRoche and then at Bristol-Myers Squibb, wherehe directed cardiovascular marketing, before joining a medical educationcompany (Medicus Worldwide Group in Manhattan) as president and managingdirector of Science and Medicine. A bachelor, he lives in Princetonin Bainbridge Estates.”After my Science and Medicine tenure, I had some good clientrelationships and decided to try to translate that into a business,”says Beck, who expects to have $10 million in billings this year.Cytocom, 231 Clarksville Road, Suite 1, West Windsor08550-1505. Gordon Beck, managing director. 609-378-2600; fax, 609-378-2610.Home page: www.cytocom.comTop Of PagePharma Ad Agency CDM ExpandsAfter two years the Princeton office of the ad agencythat did the Viagra/Bob Dole commercial — CDM — has expandedfrom 214 Carnegie Center to bigger quarters at 302 Carnegie. The phoneand fax are new. Headquartered in Manhattan at East 22nd Street, thefirm focuses on the pharmaceutical industry. Among its accounts areBristol-Myers Squibb, Wyeth, Janssen Pharmaceutica, and Johnson &Johnson. It has another office in Red Bank and has 350 workers overall.The managing partners are Ashley Schofield (creative director-art),Kyle Barich (director client services) and Gerard McLaughlin (creativedirector-copy).CDM at Princeton, 302 Carnegie Center, Suite 102,Princeton 08540. Kyle Barich, director of client services. 609-716-4400.Home page: www.clinedavis.comTop Of PageKorean Pharma Expands at CarnegieThe pharmaceutical division of the largest food manufacturerin Korea has moved into the Carnegie Center, where it plans to addup to 25 people to its current five-person staff.”Our plan to expand R&D in North America will require significantgrowth,” says Andrew Gorman, vice president and chief of businessdevelopment of CJ Pharma. “In Princeton we will be adding peopleprimarily in sales and marketing, regulatory, market research, projectmanagement, clinical development, and logistics.” Though CJ Pharmais classified as a pharmaceutical company, it will outsource manyelements — patent and contract law, financial analysis, humanresources, and market research.Current quarters are 3,400 square feet. “We will keep expandingat the Carnegie Center but are very open to alternative space thatfits our needs,” says Jong H. Kim, CJ’s global commercial director.”We picked the Princeton area as a hub for the east coast. Sincewe are also searching for biotech and other alliances, it puts usin a very strategic location.” The sales and marketing officeis in Fort Lee.”Our main focus is to develop additional therapeutic indicationsfor proprietary drugs in regulated markets,” says Kim. New productsto be acquired from outside sources might include specialized therapeuticareas such as anti-infectives, products with patents that might beextended with new formulations and indications, and hospital-basedproducts for acute care. “We feel that, with a smaller sales force,we can gain more profitability in a hospital segment,” says Kim.The company aims to increase revenues significantly — doublingor tripling sales by 2007 with higher than average profitability.”We anticipate initiating our first sales by third quarter 2003,”says Gorman. “By 2007 our global target for the division as awhole is $500 to $600 million or $250 million from this office. Lastyear division sales were $165 million, and this year we are targeting$200 million, including Korea and worldwide.”CJ Pharma’s Chairman H. Lee, who spent 30 years in the United Stateswith Unilever, has what Kim calls “a Western way of thinking.”The head of R&D has a similar background. Kim says the company recognizesthat in order to grow its pharma business, it has to acknowledge thewestern view of doing business.Kim and Gorman attend investment meetings, have met with representativesof various programs offered by the state, and have talked with someof the incubator programs and small business grant programs. “Althoughwe are part of a conglomerate, we view ourself as having an opportunityto grow through seed funding from various sources to help us fundspecial projects,” says Gorman. CJ went to Bristol-Myers Squibbto get Gorman.”It was a bold move to hire an American,” admits Gorman. “Thecompany recognized that there needed to be some perspective that mightnot be present in CJ Pharma. We have now a blend of Korean expertiseas well as U.S. and European expertise. Mr. Kim represents a niceblend of expertise — Latin America and the Middle East as wellas Korea. And I bring a blend of expertise in addition to North America.”Gorman went to Baylor University and took his PhD in pharmacologyand physiology at the University of Texas at San Antonio. He did postdoctoralwork at Northwestern Memorial in Chicago, taught at East CarolinaSchool of Medicine in Greenville, and went to Hoechst Roussel (nowAventis) in 1990, where he was in charge of corporate business developmentand licensing. In his last three years there he was responsible forJapan, and he had also been in charge of North American and Europe.In 1998 he moved to Bristol-Myers Squibb, and he came to CJ in April,2001. He lives in Yardley with his wife, an interior decorator, andthey have two grown daughters.Kim majored in organic chemistry at Korea University and did his master’sdegree at Oregon State in 1985. Then he worked as a research scientistat Samsung Corp. and moved to the pharmaceutical division as salesand marketing manager in 1994. When he came to the United States againhe worked in Fort Lee at CJ America, where he was general managerfor North and South America for the pharmaceutical division and openedthe market for Central and Latin America. One year ago he joined thenew firm, CJ Pharma, as director. Instead of moving to Fort Lee, anenclave for expatriate Koreans, Kim and his wife and two school-agedchildren chose to settle in Paramus.”We will continue to hire Americans with key expertise in theUnited States and Europe, making sure we keep the culture of Koreaintact,” says Gorman.Gorman’s job is to leverage the strengths of both business cultures.”One of the challenges we have in being a hybrid global Koreancompany is to reach a nice blend of keeping the positive aspect ofbeing a Korean company but also meeting the dynamics of the way thatU.S. and European companies like to operate. That is the one areain which I am trying to initiate change.””Korean people are very hard working and very dedicated, to companyand family and culture,” Gorman says. “One of the strikingthings is that the culture is very homogenuous, not only in Koreaitself but also in clusters in the United States. That is somethingthat needs to be recognized and respected. In doing business in Korea,consensus building is important and decisions are made only aftergetting to know the product, customer, and the partner.”Says Gorman: “Obtaining products and being a good strategic partnerrequires sense of urgency and dedication, but we also have to respectthe process and culture of consensus building.”One way to convey urgency is to start the work week promptly. BecauseKorea has a 14-hour time difference, that means that Gorman and Kimstart making phone calls on Sunday evening. Says Gorman: “To tryto reach a blend of timely decision making, we need to be sure allour colleagues in Korea understand the opportunity as well as we do.””With its long history, CJ Corporation is a leading Korean companyand is highly recognized in Korea and southeast Asia,” says Kim.”Korea represents one percent of the worldwide pharmaceuticalmarket. This is the only pharmaceutical office that we know of fromKorea that was established in the United States with global responsibilities.”CJ stands for the original company name Cheil Jedang.Translated, that means premiere sugar manufacturer. The Byung ChulLee family started a sugar refinery business after the Korean War.From there the company diversified into heavy industry, electronics,ship building, and consumer products such as clothing, so that nowit has more than 36 different subsidiaries. In 1987 the founder died,and CJ divested out of the Samsung group, which focuses on electronicsand heavy industry. The pharmaceutical division was created in 1984and made a separate company in 2001.”Our brand name has had a very good reputation for the past 50years in the domestic market, and we have 10,000 consumer products,”says Kim. “Now we want to globalize it, and CJ is easy to understandand read.”CJ already had a strong domestic business, but it wanted to grow,not just by getting new products but also by getting a piece of regulatedmarkets like North American and Europe. “CJ will be a specialtypharmaceutical, obtaining products from partnering and strategic agreements,obtaining products from worldwide sources for South America and southeastAsia. We are in the process of building a portfolio of branded productsand branded generics products,” says Gorman.”We tried to bring our products from Korea to the United States,”says Kim, “but the Food and Drug Administration is a big barrierto an Asian company. We wanted to commercialize products quickly,so we went to an unregulated market such as Latin America. In fiveyears our sales grew to $20 million, but there is a lot of competitionfrom India and China. When the market becomes crowded, we don’t seeany value there.”In an unregulated market, most of the business involves bidding againstcompetitors for a country’s contract. “There is no requirementfor certified good manufacturing practices,” says Kim. “Nowwe want to compete in the regulated markets to gain limited exclusivityand form alliances for FDA-approved production and manufacturing toget premium pricing.North America is not the company’s only target. For 40 to 50 yearsCJ has had strong ties with Japanese pharmaceutical and food companies,and it hopes to extend those ties to China. “Bulk production isa big issue and China is becoming very prominent in that. We are lookingat some of the biotechnology that may be emerging from China,”says Kim.Gorman expects to identify some community activities and become moreclosely associated with the state of New Jersey, as well as to doR&D with Princeton University and Rutgers and encourage exchange programsof scientists to and from Korea. Like most executives in Asian companies,Gorman and Kim are avid golfers, so some of their networking willtake place out on the links.CJ Pharma, 212 Carnegie Center, Suite 302, Princeton08540. Andrew Gorman, vice president, chief business development officer.609-897-0780; fax, 609-897-0725.Top Of PageJapanese Pharmas New in TownOtsuka Pharmaceuticals, 100 Overlook Center, ThirdFloor, Princeton 08540. Taro Iwamoto, global project manager. 609-452-2922;fax, 609-452-1441. Home page: www.otsuka.comTwo sister Japanese firms, Otsuka Pharmaceuticals andTaiho Pharmaceutical USA, have opened offices at Princeton Overlook.Otsuka Pharmaceutical has a major partnership with Bristol-Myers Squibband it will have up to a dozen employees in this office. Otsuka willconcentrate on drugs for the central nervous system, and it is partneringwith B-MS on aripiprazole an investigational treatment for schizophrenia.Headquartered in Tokyo, the company was founded by Busaburo Otsukaand is one of the largest privately held companies in the world. Manyfamily members work for the firm, including the grandson of the founder.Now Otsuka includes 32 companies and 19,000 employees, including 500in the United States. Total revenues are more than $4.5 billion, andproducts include nutraceuticals, “cosmedics,” chemical ingredients,daily necessities and household goods, food and drink products, andproducts related to environment maintenance.Otsuka started out in 1921 to develop intravenous solutions. Amongits consumer products now are food and nutraceuticals for qualityof life enhancements (fiber, sports drinks, and vitamins). Its firstconsumer product, in 1965, was OramininC, a nutritional drink. In1964 it began to focus more on pharmaceutical products, and it openeda research facility in Rockville, Maryland, in 1985. Its productsinclude a partnership with Pfizer.Taiho Pharma U.S.A. Inc., 100 Overlook Center,Third Floor, Princeton 08540. Masayuki Kobayashi, president. 609-987-9339;fax, 609-987-9332. Home page: www.taiho.co.jpTaiho Pharma USA belongs to the family of Otsuka companies.”Our mission is to bring our original anticancer drug to the patientsin the United States,” says Masayuki Kobayashi, the presidentof the United States division. He expects to have a total of 15 peopleat this office, which moved from Manhattan this fall. Taiho is partof the Otsuka group.Based in Tokyo, Taiho is a Japanese pharmaceutical company that manufacturesand develops therapies for oncology, urology, and immunology. Thedrug it is bringing to the United States, called S-1, has been usedfor two years in Japan for advanced gastric cancer and for head andneck cancer. It is in Phase 1 clinical trials in the United Statesfor advanced gastric cancer.Kobayashi opened the U.S. office in Manhattan in 1997. The son ofa pharmaceutical executive, he went to Gakushuin University in Tokyo,and worked at Japanese bank in New York before joining this pharmaceuticalfirm eight years ago. This fall he and his wife, who have three youngchildren, moved to West Windsor from Rye, New York.Top Of PageLeaving TownQuintiles Japan International Desk, 100 OverlookCenter, Princeton 08540.Mikihiko Obayashi has closed the Princeton office of Quintiles JapanInternational Desk, which interfaces with Japanese and American pharmaceuticalfirms. Though business is being conducted from the company’s NorthCarolina headquarters, some are working from home.Top Of PageHealth ExpansioniPhysicianNet, 214 Carnegie Center, Suite 200,Princeton 08540. Robert L. Maio, vice president, sales and service.609-275-8818; fax, 609-275-8819. Home page: www.iPhysicianNet.comThe healthcare firm has expanded from 103 Carnegie Center to Carnegie212, suite 200, but phone and fax are the same. Based in Scottsdale,Arizona, it offers high quality interactive video detailing for selectedphysicians (U.S. 1, May 22, 2002, and November 1, 2000). “Ourstaff size in Princeton fluctuates according to whether we are hostinga client’s call center,” says Karen Metropulos, spokesperson.The new office can accommodate call centers that might be needed.Top Of PageExpansions: CRO ClinphoneClinPhone Inc., 9 Roszel Road, Princeton 08540.Howard Goldberg, vice president. 609-524-4100; fax, 609-520-0633.Home page: www.clinphone.comClinPhone has made its move from 2,100 feet at Princeton CommerceCenter on Emmons Drive to 6,200 square feet at 1009 Lenox Drive andhas a new phone and fax. It also opened a Chicago office and willexpand to the West Coast in the next few months.Based in the United Kingdom, ClinPhone offers electronic trial managementservices to support pharmaceutical and biotechnology companies duringthe clinical research.Top Of PageNew in Town CRO EsoterixEsoterix, 20 Lake Drive, East Windsor 08520. AnthonyG. Busa, president of clinical trial center. 800-886-8992 or 609-443-2600;fax, 512-225-1273. Home page: www.esoterix.comHeaded by Anthony G. Busa, a clinical trial center fornew drug testing opened in September in 32,000 square feet on LakeDrive in East Windsor, in the Twin Rivers area. Based in Texas, thiscompany does the work of a laboratory testing company and a clinicalresearch organization. In fact, Busa most recently worked for Covanceat the Carnegie Center.Founded in 1995, Esoterix has more than 600 employees in the UnitedStates and Europe. It is privately funded through Manhattan-basedBehrman Capital, and shareholders invested an additional $5 millionearlier this year. Its net revenues increased by 18 percent last yearto $68.7 million.Esoterix has three service areas: testing for office-based physiciansand oncologists, for hospitals (a variety of service including endocrinologyand toxicology tests), and for pharmaceuticals and biotech companies(clinical trial services). In addition to its headquarters in Texasand the new Lake Drive facility, it has operations in California,Texas, Minnesota, Tennessee, Florida, and the Netherlands.East Windsor’s center offers Phase 1 and Phase 2 testing in all sixof Esoterix’s disease areas and it coordinates with the company’snew laboratory in Groningen, Netherlands. About 50 people are expectedto work here.Busa has 25 years of experience in the pharmaceutical, medical andcontract research industries. A graduate of Iona College in New Rochelle,New York, he most recently worked at Covance, where he was vice presidentof corporate relations and vice president of corporate sales.Top Of PageCrosstown MovesAtkins HF&G, 100 Canal Pointe Boulevard, Suite212, Princeton 08540. Chris J. Taylor, chief operations officer. 609-514-0900;fax, 609-514-9888. Home page: www.atkinsamericas.comFollowing the merger of Hanscomb with Faithful & Gould, the NassauStreet office of Faithful & Gould moved in with Hanscomb at 100 CanalPointe Boulevard in November, and it is now known as Atkins HanscombFaithful & Gould. It does construction auditing, meaning that it actsas a middleman between owners and contractors.The parent company, Atkins, has 15,000 employees worldwide and istraded on the London Stock Exchange. Atkins HF&G, the constructionauditing firm, has branches in 27 U.S. cities and 400 employees. About28 people work in the Canal Pointe office, but dozens more are inthe field. The company expanded from 4,000 to 5,000 feet at CanalPointe, taking some of the space formerly occupied by Justballs.comTop Of PageDown-SizingHighlands Insurance Group (HIC), 275 Phillips Boulevard,Ewing 08618. Stephen Kibblehouse, CEO. 609-896-1921. Home page:www.highlandsinsurance.comLate in November the property and casualty insurance company movedfrom 1000 Lenox Drive to smaller quarters on Phillips Boulevard inEwing.An article on November 6 incorrectly associated Highlands InsuranceGroup with ARI Insurance Companies on Franklin Corner Road. ARI isnot connected with Highlands Insurance Group, American Reliance Group,or Halliburton Company.Top Of PageDeathsRev. Robert A. Wieman, 79, on November 22 in a car accident.An engineer who worked on the Manhattan Project he was a Presbyterianminister.Clifford A. Erickson, 77, on November 28. He was a chemistfor FMC Corp. and manager of information retrieval at Jacobus PharmaceuticalCo.Elizabeth Flemer, 47, on November 30. A singer and songwriter,she taught English at Princeton Day School. A memorial service willbe Saturday, December 7, at 10:30 a.m. in Princeton University Chapel.Anthony A. Dutton, 76, on December 1. He had been an electronicstechnician at Princeton Plasma Physics Laboratory.Henry S. Patterson II, 80, on December 1. He had beenpresident of Elizabethtown Water Company and mayor of Princeton Borough.Eleanor B. Dearborn, 93, on December 2. She had been WestWindsor’s tax assessor.Next StoryCorrections or additions?This page is published by PrincetonInfo.com— the web site for U.S. 1 Newspaper in Princeton, New Jersey.
